Weekly Recap | TransMedics -6.44%, no company-specific negativeWeekly Review·Oct 3, 2026 at 08:38 AMTMDX+0.98%
Weekly Recap | TransMedics -1.31%, most brokers rate it buyWeekly Review·Sep 26, 2026 at 07:13 AMTMDX+0.98%
Weekly Recap | TransMedics +5.16%, most brokers rate it buyWeekly Review·Sep 19, 2026 at 07:01 AMTMDX+0.98%
Weekly Recap | TransMedics -8.67%, most brokers rate it buyWeekly Review·Sep 12, 2026 at 06:55 AMTMDX+0.98%
Weekly Recap | TransMedics +1.75%, late-week push toward range highWeekly Review·Sep 5, 2026 at 08:15 AMTMDX+0.98%
Weekly Recap | TransMedics -6.69%, governance probe in focusWeekly Review·Aug 29, 2026 at 06:33 AMTMDX+0.98%
Weekly Recap | TransMedics +6.99%, most brokers rate it buyWeekly Review·Aug 22, 2026 at 06:00 AMTMDX+0.98%
